TY - JOUR
T1 - Engineering pyrrolysyl-trna synthetase for the incorporation of non-canonical amino acids with smaller side chains
AU - Koch, Nikolaj G.
AU - Goettig, Peter
AU - Rappsilber, Juri
AU - Budisa, Nediljko
N1 - Funding Information:
N.G.K. acknowledges funding by the ?IB?M04: XenoGlue?-Consortium supported by the Federal Ministry of Education and Research of Germany (Grant Number: FKZ 031B0584A). This work was also performed as part of the ?Site-directed cross-linking of KLK proteases from prostate? Project funded by the Lead Agency FWF (I 3877-B21) with DFG-D-A-CH (BU1404/12-1) (P. G., N.G.K). N.B. thanks Canada Research Chairs Program (Grant Nr. 950-231971) for support. This work was partially supported by the Cluster of Excellence ?Unifying Systems in Catalysis? (UniSysCat), funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany?s Excellence Strategy?EXC 2008/1?390540038 (N.B. and J. R.)?. We are very grateful to Philipp Ochtrop (Leibniz-Forschungsinstitut f?r Moleku-lare Pharmakologie, Hackenberger Group) for his support in ESI-MS measurements. N.B. thanks to Christian Thomsen, President of the Technical University of Berlin, for his continuous support.
Funding Information:
Funding: N.G.K. acknowledges funding by the “IBÖM04: XenoGlue”-Consortium supported by the Federal Ministry of Education and Research of Germany (Grant Number: FKZ 031B0584A). This work was also performed as part of the “Site-directed cross-linking of KLK proteases from prostate” Project funded by the Lead Agency FWF (I 3877-B21) with DFG-D-A-CH (BU1404/12-1) (P. G., N.G.K). N.B. thanks Canada Research Chairs Program (Grant Nr. 950-231971) for support. This work was partially supported by the Cluster of Excellence “Unifying Systems in Catalysis” (UniSysCat), funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany’s Excellence Strategy–EXC 2008/1–390540038 (N.B. and J. R.)”.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/10/17
Y1 - 2021/10/17
N2 - Site-specific incorporation of non-canonical amino acids (ncAAs) into proteins has emerged as a universal tool for systems bioengineering at the interface of chemistry, biology, and technology. The diversification of the repertoire of the genetic code has been achieved for amino acids with long and/or bulky side chains equipped with various bioorthogonal tags and useful spectral probes. Although ncAAs with relatively small side chains and similar properties are of great interest to biophysics, cell biology, and biomaterial science, they can rarely be incorporated into proteins. To address this gap, we report the engineering of PylRS variants capable of incorporating an entire library of aliphatic “small-tag” ncAAs. In particular, we performed mutational studies of a specific PylRS, designed to incorporate the shortest non-bulky ncAA (S-allyl-L-cysteine) possible to date and based on this knowledge incorporated aliphatic ncAA derivatives. In this way, we have not only increased the number of translationally active “small-tag” ncAAs, but also determined key residues responsible for maintaining orthogonality, while engineering the PylRS for these interesting substrates. Based on the known plasticity of PylRS toward different substrates, our approach further expands the reassignment capacities of this enzyme toward aliphatic amino acids with smaller side chains endowed with valuable functionalities.
AB - Site-specific incorporation of non-canonical amino acids (ncAAs) into proteins has emerged as a universal tool for systems bioengineering at the interface of chemistry, biology, and technology. The diversification of the repertoire of the genetic code has been achieved for amino acids with long and/or bulky side chains equipped with various bioorthogonal tags and useful spectral probes. Although ncAAs with relatively small side chains and similar properties are of great interest to biophysics, cell biology, and biomaterial science, they can rarely be incorporated into proteins. To address this gap, we report the engineering of PylRS variants capable of incorporating an entire library of aliphatic “small-tag” ncAAs. In particular, we performed mutational studies of a specific PylRS, designed to incorporate the shortest non-bulky ncAA (S-allyl-L-cysteine) possible to date and based on this knowledge incorporated aliphatic ncAA derivatives. In this way, we have not only increased the number of translationally active “small-tag” ncAAs, but also determined key residues responsible for maintaining orthogonality, while engineering the PylRS for these interesting substrates. Based on the known plasticity of PylRS toward different substrates, our approach further expands the reassignment capacities of this enzyme toward aliphatic amino acids with smaller side chains endowed with valuable functionalities.
KW - aliphatic amino acids
KW - azidohomoalanine
KW - bioorthogonal reactive handles
KW - genetic code expansion
KW - non-canonical amino acids
KW - photo-methionine
KW - protein engineering
KW - pyrrolysyl-tRNA Synthetases
KW - S-allyl-L-cysteine
KW - stop codon suppression
U2 - 10.3390/ijms222011194
DO - 10.3390/ijms222011194
M3 - Article
C2 - 34681855
AN - SCOPUS:85116989479
SN - 1661-6596
VL - 22
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
IS - 20
M1 - 11194
ER -